Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.
Deep Apple Therapeutics has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Deep Apple Therapeutics's investors include Apple Tree Partners.
Deep Apple Therapeutics is headquartered in New York, United States.
Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.
Deep Apple Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deep Apple Therapeutics — Funding & Investors." VCBacked, December 14, 2023, https://www.vcbacked.co/company/deep-apple-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Deep Apple Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/deep-apple-therapeutics
{{cite web |title=Deep Apple Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/deep-apple-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated